XBIO Earnings
Latest Revenue660.6K
Latest Net Income-929695
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | -$0.41 | 660.6K | -929695 | +12.0% | +8.9% |
| Q1 2026 | -$0.20 | 806.9K | -456382 | +36.0% | +66.1% |
| Q4 2025 | -$0.27 | 0 | -579076 | — | +60.3% |
| Q3 2025 | -$0.33 | 0 | -509940 | — | -17.9% |
| Q2 2025 | -$0.45 | 589.9K | -688703 | -18.8% | +45.8% |
| Q1 2025 | -$0.59 | 593.3K | -903141 | +16.1% | +24.4% |
| Q4 2024 | -$0.68 | 0 | -1054521 | -100.0% | +10.5% |
| Q3 2024 | -$0.28 | 0 | -436671 | — | +59.4% |
| Q2 2024 | -$0.83 | 726.4K | -1273970 | — | — |
| Q1 2024 | -$0.78 | 510.8K | -1195113 | — | — |
| Q4 2023 | -$0.76 | 2.5M | -1171506 | — | — |
| Q3 2023 | -$0.69 | 0 | -1055555 | — | — |
Xenetic Biosciences (XBIO) — Earnings